CDSCO panel rejects USV Pharmaceuticals' proposal of CT study waiver for fenofibrate tablets in diabetic retinopathy Dr. Divya Colin28 April 2025 6:00 PM ISTNew Delhi: Noting that the presented safety data was not adequate in terms of long-term safety, the Subject Expert Committee (SEC) functional under...
Fenofibrate Cuts Diabetic Retinopathy Risk by 27%: LENS Trial Dr. Kamal Kant Kohli20 Aug 2024 12:16 PM ISTA groundbreaking trial presented for the first time at the ADA 2024 demonstrated that Fenofibrate significantly reduces the progression of diabetic...
LENS trial a first of its kind large scale trial shows striking 27% reduction in diabetic retinopathy progression MD Brand Connect13 Aug 2024 11:51 AM ISTPresented at the ADA Diabetes Congress 2024, the LENS TRIAL was specifically designed to investigate the effect of Fenofibrate on eye outcomes in...
Intas Pharmaceutical Gets CDSCO Panel Nod to Study Atorvastatin plus Fenofibrate FDC Dr. Divya Colin17 July 2024 5:30 PM ISTNew Delhi: The drug major Intas Pharmaceutical has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Fenofibrate Therapy Effective in Slowing Diabetic Retinopathy Progression: ADA Jacinthlyn Sylvia26 Jun 2024 10:00 AM ISTCholesterol drug fenofibrate has shown potential for slowing the progression of diabetic retinopathy in people with early retinal changes, with the...
Fenofibrate improves heart failure outcomes in patients with type 2 diabetes: ACCORD Lipid trial Medha Baranwal1 April 2022 10:45 AM ISTPorto, Portugal: Recent data from the ACCORD Lipid trial showed that fenofibrate reduces the composite of HF hospitalizations or cardiovascular...
Lupin launches generic version of Antara Capsules in US Hina Zahid5 Nov 2021 4:04 PM ISTThe company has launched generic version of Antara (Fenofibrate) capsules, in the strengths of 30 mg and 90 mg in the US, Lupin said in a regulatory...
IOL Chemicals gets Korean approval for Ibuprofen, Fenofibrate MD Editorial Team15 Oct 2021 12:47 PM ISTNew Delhi: Drug firm IOL Chemicals & Pharmaceuticals on Thursday said that it has received nod from the Korean Ministry of Food and Drug Safety...
Fenofibrate can reduce severity of coronavirus to that of common cold: Study Dr. Kamal Kant Kohli15 July 2020 12:45 AM ISTJerusalem: A widely used anti-cholesterol drug, fenofibrate, can "downgrade" the danger-level of coronavirus to that of a common cold, a Hebrew...
USFDA approval for anti-cholesterol tablet by Lupin Meghna A Singhania21 Aug 2015 2:55 PM ISTLupin will now market a generic version of Teva’s Fenofibrate Tablets in the American marketPharmaceutical major Lupin Ltd recently announced that it...
